| Cyclooxygenase-2 (COX-2): first immunohistochemical marker distinguishing early cutaneous melanomas from benign melanocytic skin tumours BW Chwirot, L Kuzbicki Melanoma Research 17 (3), 139-145, 2007 | 64 | 2007 |
| Expression of cyclooxygenase-2 in benign naevi and during human cutaneous melanoma progression L Kuzbicki, A Sarnecka, BW Chwirot Melanoma Research 16 (1), 29-36, 2006 | 63 | 2006 |
| JARID1B expression in human melanoma and benign melanocytic skin lesions L Kuzbicki, D Lange, A Straczynska-Niemiec, BW Chwirot Melanoma Research 23 (1), 8-12, 2013 | 29 | 2013 |
| The value of cyclooxygenase-2 expression in differentiating between early melanomas and histopathologically difficult types of benign human skin lesions L Kuzbicki, D Lange, A Straczynska-Niemiec, BW Chwirot Melanoma Research 22 (1), 70-76, 2012 | 24 | 2012 |
| Intratumoral expression of cyclooxygenase-2 (COX-2) is a negative prognostic marker for patients with cutaneous melanoma L Kuzbicki, D Lange, A Stanek-Widera, BW Chwirot Melanoma Research 26 (5), 448-456, 2016 | 21 | 2016 |
| Different expression of cyclooxygenase-2 (COX-2) in selected nonmelanocytic human cutaneous lesions L Kuzbicki, D Lange, A Stanek-Widera, BW Chwirot Folia Histochemica et Cytobiologica 49 (3), 381-388, 2011 | 19 | 2011 |
| Cyclin-dependent kinase 2 expression in human melanomas and benign melanocytic skin lesions L Kuzbicki, E Aladowicz, BW Chwirot Melanoma research 16 (5), 435-444, 2006 | 19 | 2006 |
| Cyclooxygenase-2 immunohistochemistry in human melanoma: differences between results obtained with different antibodies L Kuzbicki, D Lange, BW Chwirot Melanoma Research 19 (5), 294-300, 2009 | 16 | 2009 |
| Stromal, rather than epithelial cyclooxygenase-2 (COX-2) expression is associated with overall survival of breast cancer patients J Urban, L Kuzbicki, G Szatkowski, A Stanek-Widera, D Lange, ... BMC Cancer 14, 732, 2014 | 9 | 2014 |
| Prognostic significance of RBP2-H1 variant of JARID1B in melanoma Ł Kuźbicki, D Lange, A Stanek-Widera, BW Chwirot BMC Cancer 17, 854, 2017 | 8 | 2017 |
| Different expression of lysosome-associated membrane protein-1 in human melanomas and benign melanocytic lesions L Kuzbicki, B Gajo, BW Chwirot Melanoma Research 16 (3), 235-243, 2006 | 8 | 2006 |
| Immunohistochemical detectability of cyclooxygenase-2 expression in cells of human melanocytic skin lesions: A methodological review Ł Kuźbicki, AA Brożyna Journal of Cutaneous Pathology 47 (4), 363-380, 2020 | 5 | 2020 |
| Cyclin-dependent Kinase 2 (CDK-2) expression in nonmelanocytic human cutaneous lesions L Kuzbicki, D Lange, A Stanek-Widera, BW Chwirot Applied Immunohistochemistry & Molecular Morphology 18 (4), 357-364, 2010 | 5 | 2010 |
| Expression of Cyclooxygenase-2 in Human Epithelial Skin Lesions: A Systematic Review of Immunohistochemical Studies. Ł Kuźbicki, AA Brożyna Applied Immunohistochemistry & Molecular Morphology 29 (3), 163-174, 2021 | 4 | 2021 |
| Different detectability of cyclooxygenase-2 (COX-2) protein in standard paraffin sections and tissue microarrays of human melanomas and naevi–Comparative study L Kuzbicki, J Urban, BW Chwirot Pathology-Research and Practice 210 (9), 591-595, 2014 | 4 | 2014 |
| The detectability of intraepidermal melanocytes - a narrative review of immunohistochemical studies Ł Kuźbicki, AA Brożyna Journal of Cutaneous Pathology 49 (12), 1074-1089, 2022 | 3 | 2022 |
| Altered Splicing of JARID1B in Development of Human Cutaneous Melanoma? L Kuzbicki, D Lange, A Straczynska-Niemiec, BW Chwirot Applied Immunohistochemistry & Molecular Morphology 24 (3), 188-192, 2016 | 3 | 2016 |
| Near-infrared, wavelength, and illumination scanning holographic tomography P Ossowski, A Kuś, W Krauze, S Tamborski, M Ziemczonok, Ł Kuźbicki, ... Biomedical Optics Express 13 (11), 5971-5988, 2022 | 2 | 2022 |
| Enhanced intratumoral expression of RNF2 is a favorable prognostic factor for patients with cutaneous melanoma? Ł Kuźbicki, D Lange, A Stanek-Widera, A Glińska, BW Chwirot Oncotarget 9 (25), 17656-17663, 2018 | 2 | 2018 |
| Cyclooxygenase‐2 overexpression as indicator of favorable clinicopathological phenotype and better survival of colorectal cancer patients: Fact or artifact? BW Chwirot, J Urban, L Kuzbicki Basic and Applied Pathology 4 (1), 33-33, 2011 | 1 | 2011 |
